Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in ENOV — Enovis CORP

CIK 861177 NEW YORK, NY
Back to ENOV Full portfolio

Position in ENOV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,376,413
-$345,939 QoQ
Shares Held
163,112
-0.3% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 253 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 53% Shared 0% None 47%

Common Shares in ENOV Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,748,157,927 across 62 Medical Devices names. ENOV ranks #27 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 12,835,753 $1,164,716,222
2 SYK
Stryker Corp
 2,689,376 $846,723,135
3 DXCM
Dexcom Inc
 11,261,876 $758,487,343
4 BSX
Boston Scientific Corp
 13,091,481 $558,744,402
5 EW
Edwards Lifesciences Corp
 5,488,643 $496,502,640
6 GEHC
GE HealthCare Technologies Inc.
 2,541,393 $162,674,562
7 ZBH
Zimmer Biomet Holdings, Inc.
 1,457,553 $125,480,733
8 BIO
Bio-Rad Laboratories, Inc.
 418,884 $122,988,525

All Filings in ENOV

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,376,413 163,112
2026-03-31 $3,722,352 163,620
2025-12-31 $6,937,983 260,435
2025-09-30 $4,041,527 133,208
2025-06-30 $7,190,688 229,295
2025-03-31 $6,929,074 181,342
2024-12-31 $7,296,145 166,275
2024-09-30 $5,923,848 137,604
2024-06-30 $6,214,997 137,500
2024-03-31 $5,019,229 80,372
2023-12-31 $4,502,437 80,372
2023-09-30 $4,178,797 79,249
2023-06-30 $5,162,234 80,509
2023-03-31 $4,306,423 80,509
2022-12-31 $3,822,878 71,429
2022-09-30 $3,133,908 68,025
2022-06-30 $4,226,090 76,838
2022-03-31 $8,565,037 215,256